IP Verse

Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als - EP1714960B1

PatentPatent Analysis

EP1714960

MITSUBISHI PHARMA
Application Number
EP05709984A
Filing Date
Feb 9, 2005
Status
Revoked
Aug 21, 2020
Grant Date
Mar 28, 2018
External Links
Slate, Register, Google Patents

Bibliography

The patent EP1714960B1 was granted to Mitsubishi Pharma on Mar 28, 2018 following the initial filing on Feb 9, 2005 under the application number EP05709984A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDDec 20, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents